- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Genmab (Plainsboro, NJ)
- …purpose.Genmab is looking for a dynamic, science-driven people leader to head our Clinical Pharmacology & Quantitative Sciences team. Do you get excited by our well ... innovation powerhouse. The RoleYou will act as functional leader of our Clinical Pharmacology & Quantitative Sciences (CPQS) group, currently consisting of 25+… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …well as other research areas centered around rare diseases and immune disorders.SummaryThe Director, Clinical Safety, will be a product safety lead or part of a ... and provide safety leadership including but not limited to clinical studies, post-marketing surveillance, signal detection and management, important safety… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
